Source:http://linkedlifedata.com/resource/pubmed/id/17934354
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-10-15
|
pubmed:abstractText |
Homocysteine has been proposed as a potentially modifiable risk factor for arterial and venous vascular disease. This notion is supported by a large body of literature derived from observations in patients with rare inborn errors of metabolism associated with homocystinuria, experimental studies, which show that homocysteine promotes atherogenesis and thrombosis and epidemiological studies, which in general suggest a graded and independent relationship between homocysteine and atherothrombotic vascular risk.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1065-6251
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-7
|
pubmed:meshHeading |
pubmed-meshheading:17934354-Atherosclerosis,
pubmed-meshheading:17934354-Homocysteine,
pubmed-meshheading:17934354-Humans,
pubmed-meshheading:17934354-Meta-Analysis as Topic,
pubmed-meshheading:17934354-Metabolism, Inborn Errors,
pubmed-meshheading:17934354-Myocardial Ischemia,
pubmed-meshheading:17934354-Randomized Controlled Trials as Topic,
pubmed-meshheading:17934354-Stroke,
pubmed-meshheading:17934354-Thromboembolism
|
pubmed:year |
2007
|
pubmed:articleTitle |
Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?
|
pubmed:affiliation |
Department of Medicine, McMaster University, Hamilton, Ontario, Canada. lonnem@mcmaster.ca
|
pubmed:publicationType |
Journal Article,
Review
|